No connection

Search Results

GTES

NEUTRAL
$25.54 Live
Gates Industrial Corporation plc · NYSE
$17.79 52W Range $28.47
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
$6.5B
P/E
26.6
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
70%
GTES presents a stark contradiction between operational performance and deterministic health metrics. While the company boasts an exceptional 25-quarter track record of earnings beats and strong multi-year price appreciation, the Piotroski F-Score of 0/9 indicates severe deterioration in fundamental financial health. The significant gap between the trailing P/E (26.60) and Forward P/E (13.75) suggests high growth expectations, but the lack of a dividend and bearish technical trend offset this optimism.

Key Strengths

Exceptional earnings consistency with beats in 3 of the last 4 quarters and a long-term track record of 25 quarters
Strong long-term price performance (+89.6% over 3 years)
Attractive Forward P/E (13.75) relative to trailing P/E (26.60), implying expected earnings growth
Solid market capitalization of $6.50B providing institutional scale
Recent short-term price momentum (+15.5% in the last month)

Key Risks

Critical financial health warning indicated by a Piotroski F-Score of 0/9
Bearish technical trend (0/100) despite recent monthly gains
Lack of dividend yield or dividend strength (0/100)
Neutral insider sentiment (40/100) with zero buy/sell activity in 6 months
Missing critical liquidity and solvency data (Debt/Equity, Current Ratio)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
46
Moderate
Value
60
Future
75
Past
85
Health
10
Dividend
0
AI Verdict
High-Risk Growth
Key drivers: Consistent EPS beats, Severe Piotroski F-Score failure, Strong 3Y price trend, Low Forward P/E
Confidence
75%
Value
60/100

Ref P/E: Trailing 26.60 vs Forward 13.75

Positives
  • Forward P/E is significantly lower than trailing P/E
Watchpoints
  • Trailing P/E of 26.60 is relatively high for the industrial sector
Future
75/100

Ref Growth rates and Earnings Track Record

Positives
  • Consistent history of exceeding analyst expectations
  • Positive YoY EPS growth (+5.6%)
Watchpoints
  • Recent Q/Q EPS growth is slightly negative (-2.6%)
Past
85/100

Ref Historical price performance

Positives
  • Strong 1Y (+41.5%) and 3Y (+89.6%) price returns
Watchpoints
No urgent risks highlighted.
Health
10/100

Ref Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 0/9 is a maximum red flag for financial health
Dividend
0/100

Ref Dividend Strength 0/100

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout recorded

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$25.54

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for GTES and closest competitors.

Updated 2026-04-27
GTE
Gates Industrial Corporation plc
Primary
5Y
+45.9%
3Y
+89.6%
1Y
+41.5%
6M
-1.8%
1M
+15.5%
1W
-0.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
26.6
Forward P/E
13.75
PEG Ratio
N/A
P/B Ratio
1.94
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$6.5B

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth +3.23%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.9B
Gross Margin
38.0%
Op. Margin
13.5%
Net Margin
6.0%
Total Assets
$7.2B
Liabilities
$3.5B
Equity
$3.3B
Debt/Equity
1.04x
Operating CF
$0.3B
CapEx
$-0.0B
Free Cash Flow
$0.2B
FCF Yield
88%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-01
$N/A
2026-02-12
$0.38
+4.0% surprise
2025-10-29
$0.39
+5.4% surprise
2025-07-30
$0.39
+3.0% surprise

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

NEELY WILSON S.
Director
Stock Award
2026-03-04
6,097 shares
BRACKEN CRISTIN C.
Officer
Stock Award
2026-03-04
9,975 shares
PITSTICK THOMAS G.
Officer
Stock Award
2026-03-04
10,625 shares
SIMPKINS NEIL P
Director
Stock Award
2026-03-04
11,623 shares
CANTIE JOSEPH S.
Director
Stock Award
2026-03-04
6,097 shares
JUREK IVO
Chief Executive Officer
Stock Award
2026-03-04
63,891 shares
ELIASSON FREDRIK J
Director
Stock Award
2026-03-04
6,097 shares
MALLARD LAWRENCE BROOKS
Chief Financial Officer
Stock Award
2026-03-04
16,552 shares
ZHANG MOLLY PEIFANG
Director
Stock Award
2026-03-04
6,097 shares
IRELAND JAMES W
Director
Stock Award
2026-03-04
6,097 shares
MAINS STEPHANIE K.
Director
Stock Award
2026-03-04
6,097 shares
BRACKEN CRISTIN C.
Officer
Stock Award
2026-02-27
16,930 shares
PITSTICK THOMAS G.
Officer
Stock Award
2026-02-27
18,802 shares
JUREK IVO
Chief Executive Officer
Stock Award
2026-02-27
112,619 shares
PATOUHAS JOHN S
Officer
Stock Award
2026-02-27
2,431 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-04-20

GTES filed a definitive proxy statement on April 20, 2026, providing shareholders with necessary information to vote on matters at the company's upcoming meeting.

10-K
10-K
2026-02-12

GTES filed its annual 10-K report on February 12, 2026. Specific financial highlights and risk factors are detailed within the filing's Management's Discussion and Analysis and Risk Factors sections.

8-K
8-K
2026-02-12

GTES filed an 8-K on February 12, 2026, likely to announce its annual financial results.

10-Q
10-Q
2025-10-29

GTES filed its 10-Q on October 29, 2025. The provided excerpt identifies the inclusion of Risk Factors under Item 1A, although specific financial highlights and detailed risk disclosures were not included in the available text.

8-K
8-K
2025-10-29

GTES likely filed this 8-K to report its third-quarter financial results for the period ending September 30, 2025.

10-Q
10-Q
2025-07-30

GTES filed its quarterly 10-Q report on July 30, 2025. While specific financial metrics were not provided in the excerpt, the filing includes a detailed section on Risk Factors under Item 1A.

8-K
8-K
2025-07-30

GTES filed an 8-K on July 30, 2025, likely to announce its second-quarter financial results.

8-K
8-K
2025-06-10
10-Q
10-Q
2025-04-30

GTES filed its 10-Q on April 30, 2025. While specific financial highlights were not provided in the excerpt, the filing includes a dedicated section for risk factors under Item 1A.

8-K
8-K
2025-04-30

GTES filed an 8-K on April 30, 2025, likely to announce its quarterly financial results.

DEF 14A
DEF 14A
2025-04-17
8-K
8-K
2025-03-31
8-K
8-K
2025-02-06
10-K
10-K
2025-02-06
8-K
8-K
2024-12-23
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Barclays
2026-04-01
Maintains
Overweight Overweight
Morgan Stanley
2026-03-11
Maintains
Equal-Weight Equal-Weight
Evercore ISI Group
2026-02-23
Maintains
In-Line In-Line
Citigroup
2026-02-13
Maintains
Buy Buy
Barclays
2026-02-13
Maintains
Overweight Overweight
UBS
2026-01-05
Maintains
Buy Buy
JP Morgan
2025-12-16
Maintains
Overweight Overweight
Wells Fargo
2025-11-14
init
Equal-Weight
UBS
2025-11-06
Maintains
Buy Buy
JP Morgan
2025-10-30
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning GTES from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile